anti-Crotalus durissus terrificus venom L-Amino acid oxidase antibody product blog
Tags: Antibody; Polyclonal Antibody; Crotalus durissus terrificus venom L-Amino acid oxidase; anti-Crotalus durissus terrificus venom L-Amino acid oxidase antibody;
The L-Amino acid oxidase n/a (Catalog #MBS573271) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Rabbit anti Crotalus durissus terrificus venom L-Amino acid oxidase reacts with Serpent and may cross-react with other species as described in the data sheet. MyBioSource\'s L-Amino acid oxidase can be used in a range of immunoassay formats including, but not limited to, Immunoprecipitation (IP). Researchers should empirically determine the suitability of the L-Amino acid oxidase n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The reagents were evaluated for potency, purity and specificity using most or all of the following techniques: immunoelectrophoresis, cross-immunoelectrophoresis, single radial immunodiffusion (Ouchterlony), block titration, ELISA, immunoblotting and enzyme inhibition. This product is intended for use in precipitating and non-precipitating antibody-binding assays (such as e.g., ELISA and Western blotting and immunofluorescence or histochemical techniques); to prepare an insoluble immuno-affinity adsorbent; for labelling with a marker of the customer�s own choice.
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing L-Amino acid oxidase are readily searchable from our website. Different antibodies against the same target such as L-Amino acid oxidase may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.